Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

AES is principally a merger-arbitrage security after stockholders approved its acquisition by the GIP- and EQT-led consortium. The contractual consideration is $15.00 per share in cash, compared with AES's displayed price of $14.75 on August 31, 2026. Stockholder approval substantially advanced the transaction, but federal, state and foreign regulatory approvals and other customary conditions remain, with closing expected in late 2026 or early 2027. The limited remaining headline upside must therefore be weighed against closing delay or failure risk. Ordinary-course dividends may continue before closing, subject to Board approval.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets8 analysts · as of 18 Aug 2026
Low · most bearish analyst$15.00
Mean target$15.00
High · most bullish analyst$15.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$10.6915%

A regulatory denial, termination or material delay prevents timely completion. The $10.69 downside reference is the issuer's pre-rumor 30-day volume-weighted average price implied by the disclosed $15.00 consideration and 40.3% premium, rounded to the nearest cent; it is a transaction-failure reference rather than a fresh analyst consensus target.

Base CaseCentral scenario
$15.0060%
Matches the consensus mean

The transaction receives the outstanding regulatory approvals and closes by early 2027 at $15.00 per share. Stockholders have already approved the acquisition, while the remaining discount reflects time value and residual regulatory and execution risk.

Bull CaseUpside scenario
$15.0025%

The remaining approvals arrive promptly and the transaction closes near the early end of the issuer's window. Stockholders receive the contractual $15.00 cash consideration, with the possibility of ordinary-course dividends declared before closing subject to Board approval.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • AES stockholders approved the transaction, with approximately 97.92% of votes cast supporting it on the preliminary count.
  • The consortium stated that it will fund 100% of the purchase price with equity.
  • AES expects ordinary-course dividends to continue until closing, subject to approval by its Board.
Sign in / Sign up to read more
Key Investment Risks
  • Closing remains contingent on applicable federal, state and foreign regulatory approvals and other customary conditions.
  • The issuer's late-2026 or early-2027 closing window exposes investors to timing and opportunity-cost risk.
  • If the transaction fails, AES has stated that its capital requirements beyond 2027 could otherwise require a dividend reduction or elimination and/or substantial equity issuance.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.